Multiple studies indicated that FASN is a potential prognostic marker and therapeutic target of cancers, including breast cancer [30, 31], while miR-15a-16-1 and miR-497-195 play a tumor suppressive role. This evidence concerns the gene FASN and breast carcinoma.